• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease.胰岛素样生长因子-I、胰岛素样生长因子结合蛋白-1与儿童克罗恩病中的胰岛素
Gut. 1993 Jul;34(7):944-7. doi: 10.1136/gut.34.7.944.
2
Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.肾移植后生长迟缓的泼尼松治疗儿童的生长激素、胰岛素样生长因子-I(IGF-I)和-II、IGF结合蛋白-1和-3以及皮质醇水平。
J Clin Endocrinol Metab. 1993 Oct;77(4):932-8. doi: 10.1210/jcem.77.4.7691864.
3
Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease.胰岛素样生长因子-I(IGF-I)和胰岛素样生长因子结合蛋白-3(IGFBP-3)对克罗恩病儿童及青少年治疗干预的反应性。
Clin Endocrinol (Oxf). 1998 Oct;49(4):483-9. doi: 10.1046/j.1365-2265.1998.00562.x.
4
Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome.库欣综合征患者血清中的胰岛素样生长因子(IGF)I和II以及IGF结合蛋白(IGFBP)1、2和3
Acta Endocrinol (Copenh). 1993 May;128(5):397-404.
5
Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.使用胰岛素样生长因子结合蛋白-2(IGFBP-2)、IGFBP-3和IGF-I评估矮小儿童的生长激素状态。
J Clin Endocrinol Metab. 1993 Nov;77(5):1294-9. doi: 10.1210/jcem.77.5.7521346.
6
The effect of dietary protein supplementation on insulin-like growth factors (IGFs) and IGF-binding proteins in children with shigellosis.膳食蛋白质补充对志贺氏菌病患儿胰岛素样生长因子(IGFs)及IGF结合蛋白的影响。
J Clin Endocrinol Metab. 1993 Dec;77(6):1516-21. doi: 10.1210/jcem.77.6.7505287.
7
The insulin-like growth factor (IGF) system and its relation to infliximab treatment in adult patients with Crohn's disease.胰岛素样生长因子(IGF)系统及其与成年克罗恩病患者英夫利昔单抗治疗的关系。
Scand J Gastroenterol. 2007 Apr;42(4):464-70. doi: 10.1080/00365520601010115.
8
Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with omega-3 or omega-6 fatty acids and corticosteroids.
Scand J Gastroenterol. 2005 Oct;40(10):1214-21. doi: 10.1080/00365520510015728.
9
Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.厄瓜多尔生长激素受体缺陷患者杂合子亲属中血清胰岛素样生长因子、胰岛素样生长因子结合蛋白及生长激素结合蛋白的表达
J Clin Endocrinol Metab. 1992 Apr;74(4):743-50. doi: 10.1210/jcem.74.4.1372321.
10
Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood.慢性肾衰竭患儿的血清胰岛素样生长因子(IGFs)及IGF结合蛋白1、2和3:与身高及肾小球滤过率的关系。欧洲儿童慢性肾衰竭营养治疗研究组
J Clin Endocrinol Metab. 1995 Sep;80(9):2684-91. doi: 10.1210/jcem.80.9.7545697.

引用本文的文献

1
A Theoretical Link Between the GH/IGF-1 Axis and Cytokine Family in Children: Current Knowledge and Future Perspectives.儿童生长激素/胰岛素样生长因子-1轴与细胞因子家族之间的理论联系:当前认知与未来展望
Children (Basel). 2025 Apr 11;12(4):495. doi: 10.3390/children12040495.
2
Insulin-like Growth Factor-1 Synergizes with IL-2 to Induce Homeostatic Proliferation of Regulatory T Cells.胰岛素样生长因子-1 与白细胞介素-2 协同诱导调节性 T 细胞的稳态增殖。
J Immunol. 2023 Oct 1;211(7):1108-1122. doi: 10.4049/jimmunol.2200651.
3
Chronic inflammation and the growth hormone/insulin-like growth factor-1 axis.慢性炎症与生长激素/胰岛素样生长因子-1轴
Cent Eur J Immunol. 2020;45(4):469-475. doi: 10.5114/ceji.2020.103422. Epub 2021 Jan 30.
4
Supplementation of Bovine Colostrum in Inflammatory Bowel Disease: Benefits and Contraindications.牛初乳在炎症性肠病中的补充:益处和禁忌证。
Adv Nutr. 2021 Mar 31;12(2):533-545. doi: 10.1093/advances/nmaa120.
5
Biomarkers of Systemic Inflammation and Growth in Early Infancy are Associated with Stunting in Young Tanzanian Children.早期婴儿期全身炎症和生长的生物标志物与坦桑尼亚儿童的生长迟缓有关。
Nutrients. 2018 Aug 24;10(9):1158. doi: 10.3390/nu10091158.
6
Characterization of Growth Hormone Resistance in Experimental and Ulcerative Colitis.实验性和溃疡性结肠炎中生长激素抵抗的特征。
Int J Mol Sci. 2017 Sep 23;18(10):2046. doi: 10.3390/ijms18102046.
7
Growth Hormone Resistance-Special Focus on Inflammatory Bowel Disease.生长激素抵抗——特别关注炎症性肠病
Int J Mol Sci. 2017 May 9;18(5):1019. doi: 10.3390/ijms18051019.
8
Endocrine therapy for growth retardation in paediatric inflammatory bowel disease.儿科炎症性肠病生长迟缓的内分泌治疗。
Paediatr Drugs. 2014 Feb;16(1):29-42. doi: 10.1007/s40272-013-0046-0.
9
Mathematical modelling to restore circulating IGF-1 concentrations in children with Crohn's disease-induced growth failure: a pharmacokinetic study.数学建模恢复克罗恩病诱导生长障碍儿童循环 IGF-1 浓度:一项药代动力学研究。
BMJ Open. 2013 May 28;3(5):e002737. doi: 10.1136/bmjopen-2013-002737.
10
Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?胰岛素样生长因子-I 对免疫功能的调节:自身免疫性疾病的潜在治疗靶点?
Pharmacol Rev. 2010 Jun;62(2):199-236. doi: 10.1124/pr.109.002469. Epub 2010 Apr 14.

本文引用的文献

1
Somatomedin activity in the Mauriac syndrome.毛里阿氏综合征中的生长调节素活性。
J Pediatr. 1980 Oct;97(4):598-600. doi: 10.1016/s0022-3476(80)80017-5.
2
Nocturnal growth hormone and gonadotrophin secretion in growth retarded children with Crohn's disease.患有克罗恩病的生长发育迟缓儿童的夜间生长激素和促性腺激素分泌情况
Gut. 1981 Nov;22(11):933-8. doi: 10.1136/gut.22.11.933.
3
The somatomedins.
Adv Pediatr. 1981;28:293-317.
4
Somatomedin activity and growth hormone secretion. I. Changes related to body weight in anorexia nervosa.生长调节素活性与生长激素分泌。I. 神经性厌食症中与体重相关的变化。
Acta Paediatr Scand. 1980 Jan;69(1):37-41. doi: 10.1111/j.1651-2227.1980.tb07026.x.
5
Somatomedins (second of two parts).生长调节素(两部分中的第二部分)
N Engl J Med. 1980 Feb 21;302(8):438-46. doi: 10.1056/NEJM198002213020805.
6
Somatomedins (first of two parts).生长调节素(两部分中的第一部分)。
N Engl J Med. 1980 Feb 14;302(7):371-80. doi: 10.1056/NEJM198002143020704.
7
Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II.1965年英国儿童从出生到成年的身高、体重、身高增长速度和体重增长速度标准:第二部分。
Arch Dis Child. 1966 Dec;41(220):613-35. doi: 10.1136/adc.41.220.613.
8
Nyctohemeral growth hormone levels in children with growth retardation and inflammatory bowel disease.生长发育迟缓与炎症性肠病患儿的昼夜生长激素水平
Gut. 1973 Mar;14(3):191-5. doi: 10.1136/gut.14.3.191.
9
Severe growth retardation in children with inflammatory bowel disease.炎症性肠病患儿的严重生长发育迟缓
Pediatrics. 1970 Mar;45(3):386-93.
10
Effect of administered human growth hormone on growth retardation in inflammatory bowel disease.注射用人生长激素对炎症性肠病生长迟缓的影响。
Am J Dig Dis. 1974 May;19(5):411-6. doi: 10.1007/BF01255604.

胰岛素样生长因子-I、胰岛素样生长因子结合蛋白-1与儿童克罗恩病中的胰岛素

Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease.

作者信息

Thomas A G, Holly J M, Taylor F, Miller V

机构信息

Department of Gastroenterology, Booth Hall Children's Hospital, Blackley, Manchester.

出版信息

Gut. 1993 Jul;34(7):944-7. doi: 10.1136/gut.34.7.944.

DOI:10.1136/gut.34.7.944
PMID:7688335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1374231/
Abstract

Twenty nine children with Crohn's disease were studied before and after treatment with steroids or an elemental diet to assess the effect of disease activity and treatment on serum insulin like growth factor I (IGF-I), insulin like growth factor binding protein (IGFBP-1), and insulin concentrations. The median serum IGF-I concentration was lower in patients with active disease than in matched controls, and lower in stunted than well grown patients, but insulin and IGFBP-1 concentrations were not significantly different between any group. After four weeks of either treatment there was an increase in the median serum IGF-I concentration; this was greater in the steroid group than the elemental diet group. The median serum insulin concentration increased and median serum IGFBP-1 concentration decreased in the steroid treated group but not in the elemental diet group. These changes were accompanied by a greater and more sustained increase in energy intake in the steroid group. Despite this the median height velocity SD score was greater in the elemental diet group than in the steroid group.

摘要

对29名克罗恩病患儿在接受类固醇或要素饮食治疗前后进行了研究,以评估疾病活动度和治疗对血清胰岛素样生长因子I(IGF-I)、胰岛素样生长因子结合蛋白(IGFBP-1)及胰岛素浓度的影响。活动期疾病患儿的血清IGF-I浓度中位数低于匹配的对照组,发育迟缓患儿低于生长良好的患儿,但胰岛素和IGFBP-1浓度在任何组间均无显著差异。两种治疗四周后,血清IGF-I浓度中位数均升高;类固醇组升高幅度大于要素饮食组。类固醇治疗组血清胰岛素浓度中位数升高,血清IGFBP-1浓度中位数降低,而要素饮食组则无变化。这些变化伴随着类固醇组能量摄入的增加幅度更大且更持久。尽管如此,要素饮食组的身高速度标准差评分中位数仍高于类固醇组。